BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 19, 2017
View Archived Issues
Complete remissions maintained with blinatumomab in acute lymphocytic leukemia patients
Read More
CRAFT computational approach identifies new targets for treating epilepsy
Read More
Phase II data does not support adding CC-486 to fulvestrant for ER+ HER2-metastatic breast cancer
Read More
NCI recruiting participants in phase I trial of Aza-TdC in patients with solid tumors
Read More
Fresenius submits first biosimilar MAA to EMA
Read More
Phase II trial of LJPC-401 in hereditary hemochromatosis begins
Read More
Bristol-Myers Squibb's Yervoy recommended for approval in Europe for pediatric melanoma
Read More
ISA and Regeneron collaborate to study ISA-101 with cemiplimab in head and neck and cervical cancers
Read More
European MAA for patisiran submitted by Sanofi and Alynylam
Read More
FDA grants priority review to Opdivo plus Yervoy sBLA for advanced renal cell carcinoma
Read More
MHRA partners with WHO and Gates Foundation to improve safety monitoring
Read More
Achillion Pharmaceuticals' ACH-4471 receives U.S. orphan drug designation
Read More
EMA committee recommends against approval of Aplidin for multiple myeloma.
Read More
Orchard Therapeutics contracts Yposkesi for lentiviral vector batches
Read More
Ultragenyx Pharmaceutical sells Rare Pediatric Disease Priority Review Voucher to Novartis
Read More
GC-4419 meets primary endpoint in phase II trial of oral mucositis in chemotherapy patients
Read More
SF-0166 well tolerated in phase I/II wet AMD trial
Read More
Netarsudil ophthalmic solution approved in the U.S. for lowering intraocular pressure
Read More
BLA accepted for Teva's fremanezumab
Read More
RXI-109 improves revision of hypertrophic scars in phase II trial
Read More
FDA breakthrough designation granted for fingolimod for pediatric multiple sclerosis
Read More
FDA Fast Track designation granted to elamipretide for Leber's hereditary optic neuropathy
Read More
Kalyra Pharmaceuticals divulges novel EGFR inhibitors
Read More
Constellation Pharmaceuticals, Genentech patent CREB-binding protein/EP300 inhibitors
Read More
KalVista Pharmaceuticals identifies novel plasma kallikrein inhibitors
Read More
New histone demethylase inhibitors synthesized at Oryzon Genomics
Read More
Taiho Pharmaceutical discovers new ribonucleoside-diphosphate reductase inhibitors
Read More